Allovectin-7
|
WikiDoc Resources for Allovectin-7 |
|
Articles |
|---|
|
Most recent articles on Allovectin-7 Most cited articles on Allovectin-7 |
|
Media |
|
Powerpoint slides on Allovectin-7 |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Allovectin-7 at Clinical Trials.gov Clinical Trials on Allovectin-7 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Allovectin-7
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Allovectin-7 Discussion groups on Allovectin-7 Patient Handouts on Allovectin-7 Directions to Hospitals Treating Allovectin-7 Risk calculators and risk factors for Allovectin-7
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Allovectin-7 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Allovectin-7 is a substance that is being studied as a gene therapy agent in the treatment of cancer, such as malignant melanoma. It increases the ability of the immune system to recognize cancer cells and kill them.
External links
- Allovectin-7 entry in the public domain NCI Dictionary of Cancer Terms